Progress made toward treatment for rare, fatal neurological disease

After more than a decade of work, researchers at the University of Wisconsin–Madison’s Waisman Center reported promising results in the lab and in animal models that could set the stage for developing a treatment for Alexander disease, a rare and usually fatal neurological disease with no known cure.

After decades of service, Waisman clinician Tina Iyama-Kurtycz retires in December

Iyama-Kurtycz’s journey from an 8-year-old with a dream to a skilled clinician took her to medical school at the University of Michigan and a residency at the University of Kansas. “While at Kansas, I met a pediatrician who was taking care of children with disabilities and I realized that’s what I wanted to do,” says Iyama-Kurtycz.

Waisman Center director search advances as interim leadership is named

“Dr. Messing has been an outstanding director of this center since his appointment in 2015. He is both a superb scientist and has been a strong leader across this center’s multifaceted mission,” says Norman Drinkwater, UW–Madison associate vice chancellor for research in biological sciences.

A decade after stem cell feat, research ramps up

A decade after scientists announced the development of induced pluripotent stem cells, Waisman investigators, including Su-Chun Zhang and David Gamm, continue to use these cells to research and develop potential therapies for several disorders and conditions, such as ALS, Parkinson’s disease, spinal cord injury, and macular degeneration.